1.8700
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
4,442
2,614
2,400
1,866
Total Liabilities Net Minority Interest
1,220
968
1,411
4,895
Total Equity Gross Minority Interest
3,222
1,646
989
-3,029
Total Capitalization
3,222
1,646
989
-3,029
Preferred Stock Equity
--
--
4,180
--
Common Stock Equity
3,222
1,646
-3,191
-3,029
Capital Lease Obligations
294
48
147
169
Net Tangible Assets
3,222
1,646
989
-3,029
Working Capital
2,213
-185
231
-3,249
Invested Capital
3,222
1,646
-3,191
-3,029
Tangible Book Value
3,222
1,646
-3,191
-3,029
Total Debt
294
48
147
169
Share Issued
15,918.9790
13,947.3240
12,174.4670
10,760.8710
Ordinary Shares Number
15,918.9790
13,947.3240
12,174.4670
10,760.8710
12/31/2021 - 10/21/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1541.HK IMMUNEONCO-B
5.050
0.00%
WXXWY WuXi Biologics (Cayman) Inc.
5.17
0.00%
TIL Instil Bio, Inc.
15.46
+1.01%
ANRO Alto Neuroscience, Inc.
2.2600
+0.44%
9926.HK Akeso, Inc.
82.950
-0.90%
LPCN Lipocine Inc.
3.0000
0.00%
IMUX Immunic, Inc.
0.9800
+3.98%
ANVS Annovis Bio, Inc.
1.2200
-3.17%
BSEM BioStem Technologies, Inc.
12.17
-4.40%
RCKT Rocket Pharmaceuticals, Inc.
6.33
+2.93%